Central Pharmaceutical Joint Stock Company No3 reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was VND 91,117.04 million compared to VND 108,225.41 million a year ago. Net income was VND 18,866.92 million compared to VND 16,289.52 million a year ago. Basic earnings per share from continuing operations was VND 878 compared to VND 758 a year ago.
For the nine months, revenue was VND 311,726.67 million compared to VND 359,553.45 million a year ago. Net income was VND 74,716.42 million compared to VND 68,078.35 million a year ago. Basic earnings per share from continuing operations was VND 3,475 compared to VND 3,166 a year ago.